Advertisement

Current Urology Reports

, 15:440 | Cite as

Lower Urinary Tract Symptoms in Women with Diabetes Mellitus: A Current Review

  • Rebecca James
  • Adonis Hijaz
Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Lower Urinary Tract Symptoms & Voiding Dysfunction

Abstract

A literature review of the most current publications studying lower urinary tract symptoms (LUTS) and findings in diabetic women was conducted including articles from January 2013 to April 2014. Current reports consistently note that aging and obesity are significantly associated with worsened LUTS in diabetic women. Glucosuria has variable effects on urodynamic parameters and LUTS, but has a significant association with urinary tract infection (UTI) and incontinence at clinically relevant numbers, such as HbA1C values. The presence of severe nocturia in diabetic patients warrants careful surveillance for cardiovascular risks given the significant association with mortality. Diabetics appear to be at higher risk for colonization with the virulent, extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species in UTI. Novel therapies in glycemic control and for diabetic bladder dysfunction are undergoing animal model trials with encouraging results. The most promising of these includes stem cell therapy, although a need exists for human studies.

Keywords

Diabetes mellitus and lower urinary tract symptoms Stress urinary incontinence Urge incontinence Overactive bladder Urinary frequency Urgency Nocturia 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Rebecca James and Dr. Adonis Hijaz each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Samsioe G, Heraib F, Lidfeldt J, et al. Urogenital symptoms in women aged 50-59 years. Women's Health in Lund Area (WHILSA) Study Group. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 1999;13(2):113–7.CrossRefGoogle Scholar
  2. 2.
    Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol. 1996;87(5 Pt 1):715–21.PubMedCrossRefGoogle Scholar
  3. 3.
    Farrell SA, Allen VM, Baskett TF. Parturition and urinary incontinence in primiparas. Obstet Gynecol. 2001;97(3):350–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Brown JS, Vittinghoff E, Lin F, Nyberg LM, Kusek JW, Kanaya AM. Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002. Diabetes Care. 2006;29(6):1307–12.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Brown JS, Wing R, Barrett-Connor E, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care. 2006;29(2):385–90.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Foldspang A, Hvidman L, Mommsen S, Nielsen JB. Risk of postpartum urinary incontinence associated with pregnancy and mode of delivery. Acta Obstet Gynecol Scand. 2004;83(10):923–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Ebbesen MH, Hannestad YS, Midthjell K, Hunskaar S. Diabetes and urinary incontinence - prevalence data from Norway. Acta Obstet Gynecol Scand. 2007;86(10):1256–62.PubMedCrossRefGoogle Scholar
  8. 8.
    Danforth KN, Townsend MK, Lifford K, Curhan GC, Resnick NM, Grodstein F. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol. 2006;194(2):339–45.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549–54.PubMedCrossRefGoogle Scholar
  10. 10.
    Simkhada R. Urinary tract infection and antibiotic sensitivity pattern among diabetics. Nepal Med Coll J NMCJ. 2013;15(1):1–4.Google Scholar
  11. 11.
    Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin N Am. 1997;11(3):735–50.CrossRefGoogle Scholar
  12. 12.
    Kesah CN, Coker AO, Alabi SA, Olukoya DK. Prevalence, antimicrobial properties and beta-lactamase production of haemolytic enterobacteria in patients with diarrhoea and urinary tract infections in Legos, Nigeria. Cent Afr J Med. 1996;42(5):147–50.PubMedGoogle Scholar
  13. 13.
    Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41(3):281–8.CrossRefGoogle Scholar
  14. 14.
    Bani-Issa W, Almomani F, Eldeirawi K. Urinary incontinence among adult women with diabetes in Jordan: epidemiology, correlates and perceived impact on emotional and social well-being. J Clin Nurs. 2013.Google Scholar
  15. 15.
    Palleschi G, Pastore AL, Maggioni C, et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J Urol. 2013.Google Scholar
  16. 16.
    Ahmed HM, Osman VA, Al-Alaf SK, Al-Tawil NG. Prevalence of urinary incontinence and probable risk factors in a sample of kurdish women. Sultan Qaboos Univ Med J. 2013;13(2):269–74.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Appa AA, Brown JS, Creasman J, et al. Clinical predictors and significance of postvoid residual volume in women with diabetes. Diabetes Res Clin Pract. 2013;101(2):164–9.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.••
    Chung MS, Chuang YC, Lee JJ, Lee WC, Chancellor MB, Liu RT. Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes. Int Urol Nephrol. 2014. The alarming significance between nocturia of ≥ 3 times per night and cardiovascular mortality in diabetic patients warrants a provider to urge the patient to maintain vigilant surveillance with her primary care provider in routine cardiovascular risk screenings. In a sense, the symptom of nocturia may prove to be a valuable warning in the care of diabetic patients. Google Scholar
  19. 19.
    Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013;98(4):267–80.PubMedCrossRefGoogle Scholar
  20. 20.
    Lee WC, Wu HC, Huang KH, Wu HP, Yu HJ, Wu CC. Hyposensitivity of C-fiber afferents at the distal extremities as an indicator of early stages diabetic bladder dysfunction in type 2 diabetic women. PLoS One. 2014;9(1):e86463.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Kirschner-Hermanns R, Daneshgari F, Vahabi B, Birder L, Oelke M, Chacko S. Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011. Neurourol Urodyn. 2012;31(3):359–64.PubMedCrossRefGoogle Scholar
  22. 22.••
    Kim JH, Lee SR, Song YS, Lee HJ. Stem cell therapy in bladder dysfunction: where are we? And where do we have to go? BioMed Res Int. 2013;2013:930713. Stem cell therapy appears to have the most promising projection for future LUTS therapies, but focused efforts must be made to conduct human studies.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Daneshgari F, Liu G, Imrey PB. Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol. 2006;176(1):380–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Daneshgari F, Huang X, Liu G, Bena J, Saffore L, Powell CT. Temporal differences in bladder dysfunction caused by diabetes, diuresis, and treated diabetes in mice. Am J Physiol Regul Integr Comp Physiol. 2006;290(6):R1728–35.PubMedCrossRefGoogle Scholar
  25. 25.
    Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010;19(12):1287–92.PubMedCrossRefGoogle Scholar
  26. 26.
    Kullmann FA, Wells GI, McKenna D, Thor KB. Excitatory effects of bombesin receptors in urinary tract of normal and diabetic rats in vivo. Life Sci. 2014;100(1):35–44.PubMedCrossRefGoogle Scholar
  27. 27.
    Ren LM, Zhuo YJ, Hao ZS, He HM, Lu HG, Zhao D. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2013;150(3):1128–36.PubMedCrossRefGoogle Scholar
  28. 28.
    Changxiao H, Zhengyong Y, Shibing Y, et al. Clinical and urodynamic evaluation of women referred with diabetes mellitus. Int Urogynecol J. 2014.Google Scholar
  29. 29.
    Ding L, Song T, Yi C, et al. Transcutaneous electrical nerve stimulation (TENS) improves the diabetic cytopathy (DCP) via up-regulation of CGRP and cAMP. PLoS One. 2013;8(2):e57477.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Starer P, Libow L. Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Arch Intern Med. 1990;150(4):810–3.PubMedCrossRefGoogle Scholar
  32. 32.
    Chang TC, Chang SR, Hsiao SM, Hsiao CF, Chen CH, Lin HH. Factors associated with fecal incontinence in women with lower urinary tract symptoms. J Obstet Gynaecol Res. 2013;39(1):250–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Stav K, Shilo Y, Zisman A, Lindner A, Leibovici D. Comparison of lower urinary tract symptoms between women with detrusor overactivity and impaired contractility, and detrusor overactivity and preserved contractility. J Urol. 2013;189(6):2175–8.PubMedCrossRefGoogle Scholar
  34. 34.•
    Aswani SM, Chandrashekar U, Shivashankara K, Pruthvi B. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australas Med J. 2014;7(1):29–34. The above study discusses how diabetics appear to be at higher risk for the most virulent strains of the common UTI microbes (extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species; ESBL-EK), so continued research in therapies against these strains is warranted. E. coli has shown maximum sensitivity to carbapenems and the least susceptibility to ampicillin.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA J Am Med Assoc. 2014;311(8):844–54.CrossRefGoogle Scholar
  36. 36.
    Tsai SW, Kung FT, Chuang FC, Ou YC, Wu CJ, Huang KH. Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results. Taiwan J Obstet Gynecol. 2013;52(4):493–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Mamun Mahmud H, Qureshi S, Kumar D, Farman S. Pyuric diabetic patients: a tertiary centre experience from Karachi. Pak J Med Sci. 2014;30(1):77–80.PubMedPubMedCentralGoogle Scholar
  38. 38.•
    Macvane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med Off Publ Soc Hosp Med. 2014;9(4):232–8. The above study discusses how diabetics appear to be at higher risk for the most virulent strains of the common UTI microbes (extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species; ESBL-EK), so continued research in therapies against these strains is warranted. E. coli has shown maximum sensitivity to carbapenems and the least susceptibility to ampicillin.CrossRefGoogle Scholar
  39. 39.
    Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Urinary tract infections in patients with diabetes treated with dapagliflozin. J Diabetes Complicat. 2013;27(5):473–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Dixon L, Winkler M. Emphysematous cystitis: a tympanic bladder. BMJ Case Rep. 2013;2013.Google Scholar
  41. 41.
    Hanna-Mitchell AT, Ruiz GW, Daneshgari F, Liu G, Apodaca G, Birder LA. Impact of diabetes mellitus on bladder uroepithelial cells. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R84–93.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Wai CY, Curto TM, Zyczynski HM, et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstet Gynecol. 2013;121(5):1009–16.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Nicolle LE, Capuano G, Ways K, Usiskin K. Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study. Curr Med Res Opin. 2012;28(7):1167–71.PubMedCrossRefGoogle Scholar
  44. 44.
    Uzun H, Ogullar S, Sahin SB, et al. Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder. Int Neurourol J. 2013;17(2):67–72.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Female Pelvic Medicine and Reconstructive Surgery, Department of UrologyUniversity Hospitals Case Medical CenterClevelandUSA
  2. 2.Department of UrologyUniversity Hospitals Case Medical CenterClevelandUSA

Personalised recommendations